Basket | Login | Register


WP9: Project Coordination

Work Packages

Pharmacog Logo

Main Objectives

The overall objective of this WP is to ensure the successful implementation of this project on a scientific, financial and management level. To achieve this we will focus on 3 main areas

  1. Ensure efficient management of scientific activities (including ethics) and financial allocation/reporting
  2. Ensure effective communication between partners to support sharing best practice, maximize synergies and prevent duplication
  3. Ensure the protection and exploitation of the results of this project in an appropriate manner A Project Agreement will be signed by all the partners before the start of the project. This document will detail the management bodies, as well as the rules and duties of each partner in the project

WP Leads

Industry lead: Dr Jill Richardson (GSK)

Academic lead: Dr Alexandra Auffret (Univmed, France)

WP Partners

GSK and UnivMed



Last Updated: Tuesday 25 October 2011


  • Acknowledgements

    The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) for the Innovative Medicine Initiative under Grant Agreement No 115009.
  • Innovative Medicines Initiative
  • European Union
  • European Federation of Pharmaceutical Industries and Associations